Get the Stockscreener App
210.23
1.10%
2.28
After Hours:
210.23
Overview
News
Price History
Option Chain
Financials
Why DHR Down?
Discussions
Forecast
Stock Split
Dividend History
Danaher Corp stock is traded at $210.23, with a volume of 5.84M.
It is up +1.10% in the last 24 hours and down -13.88% over the past month.
In 1984, Danaher's founders transformed a real estate organization into an industrial-focused manufacturing company. Then, through a series of mergers, acquisitions, and divestitures, Danaher now focuses primarily on manufacturing scientific instruments and consumables in the life science and diagnostic industries after the late 2023 divestiture of its environmental and applied solutions group, Veralto.
See More
Previous Close:
$207.95
Open:
$210.61
24h Volume:
5.84M
Relative Volume:
1.57
Market Cap:
$151.18B
Revenue:
$23.88B
Net Income/Loss:
$3.90B
P/E Ratio:
39.82
EPS:
5.28
Net Cash Flow:
$5.30B
1W Performance:
+1.90%
1M Performance:
-13.88%
6M Performance:
-22.45%
1Y Performance:
-16.13%
1-Day Range:
$209.40
$213.64
1-Week Range:
$201.21
$213.64
52-Week Range:
$196.80
$281.70
Danaher Corp Stock (DHR) Company Profile
Name
Danaher Corp
Sector
Industry
Phone
(202) 828-0850
Address
2200 PENNSYLVANIA AVE. N.W., WASHINGTON, DC
Compare DHR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DHR
Danaher Corp
|
210.23 | 151.18B | 23.88B | 3.90B | 5.30B | 5.28 |
|
TMO
Thermo Fisher Scientific Inc
|
532.55 | 203.70B | 42.88B | 6.34B | 7.27B | 16.53 |
|
A
Agilent Technologies Inc
|
135.37 | 38.62B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IDXX
Idexx Laboratories Inc
|
452.77 | 37.07B | 3.90B | 887.87M | 808.08M | 10.67 |
|
IQV
Iqvia Holdings Inc
|
191.04 | 33.64B | 15.41B | 1.37B | 2.11B | 7.50 |
Danaher Corp Stock (DHR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-03-25 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Dec-23-24 | Initiated | Scotiabank | Sector Perform |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Dec-13-24 | Upgrade | BofA Securities | Neutral → Buy |
| Oct-31-24 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Oct-01-24 | Initiated | Stephens | Overweight |
| Aug-28-24 | Initiated | Wells Fargo | Equal Weight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-17-24 | Upgrade | HSBC Securities | Hold → Buy |
| Jan-24-24 | Downgrade | Barclays | Overweight → Equal Weight |
| Dec-18-23 | Initiated | HSBC Securities | Hold |
| Dec-13-23 | Resumed | Wolfe Research | Peer Perform |
| Dec-07-23 | Downgrade | Goldman | Buy → Neutral |
| Jul-19-23 | Initiated | Raymond James | Outperform |
| May-01-23 | Initiated | SVB Securities | Outperform |
| Apr-26-23 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-18-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-05-23 | Downgrade | Credit Suisse | Outperform → Neutral |
| Dec-14-22 | Initiated | Deutsche Bank | Buy |
| Oct-24-22 | Downgrade | The Benchmark Company | Buy → Hold |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Aug-17-22 | Resumed | Bernstein | Outperform |
| Jul-20-22 | Initiated | UBS | Buy |
| Jun-01-22 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Jan-11-22 | Initiated | Bernstein | Outperform |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-10-21 | Reiterated | BofA Securities | Buy |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-23-21 | Reiterated | Goldman | Buy |
| Jul-16-21 | Initiated | The Benchmark Company | Buy |
| Apr-07-21 | Resumed | Robert W. Baird | Outperform |
| Mar-03-21 | Resumed | Barclays | Overweight |
| Dec-02-20 | Initiated | Goldman | Buy |
| Nov-25-20 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-10-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jun-16-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Apr-02-20 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Mar-26-20 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-03-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Nov-15-19 | Resumed | Stifel | Hold |
| Oct-28-19 | Reiterated | Needham | Buy |
| Oct-14-19 | Resumed | Credit Suisse | Outperform |
| Jul-19-19 | Reiterated | Needham | Buy |
| Jun-11-19 | Initiated | Piper Jaffray | Neutral |
| May-30-19 | Initiated | Wolfe Research | Outperform |
| Apr-17-19 | Reiterated | Needham | Buy |
| Feb-28-19 | Reiterated | Needham | Buy |
| Feb-25-19 | Upgrade | Janney | Neutral → Buy |
| Jan-03-19 | Initiated | Needham | Buy |
| Apr-20-18 | Reiterated | Stifel | Buy |
View All
Danaher Corp Stock (DHR) Latest News
Northstar Asset Management Inc. Trims Stock Position in Danaher Co. (NYSE:DHR) - MarketBeat
Congress Asset Management Co. Has $1.73 Million Position in Danaher Co. (NYSE:DHR) - MarketBeat
Danaher Co. (NYSE:DHR) Plans Quarterly Dividend of $0.32 - MarketBeat
Danaher's Options Frenzy: What You Need to Know - Benzinga
Top Biotech Stocks To ConsiderFebruary 20th - MarketBeat
Flossbach Von Storch SE Buys 44,490 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
ING Groep NV Has $31.54 Million Position in Danaher Co. (NYSE:DHR) - MarketBeat
Danaher Co. (NYSE:DHR) is Dash Acquisitions Inc.'s 10th Largest Position - MarketBeat
Handelsbanken Fonder AB Buys 7,878 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Hemoglobin A1c (HbA1c) Testing Research Report 2025: Key - GlobeNewswire
Hemoglobin A1c (HbA1c) Testing Research Report 2025: Key Trends, Opportunities, Strategies 2019-2034Danaher Leads the Fragmented Market (6.5%), Followed by Roche and Siemens Healthineers - Yahoo Finance
Kentucky Retirement Systems Insurance Trust Fund Grows Stock Position in Danaher Co. (NYSE:DHR) - MarketBeat
GAM Holding AG Sells 1,406 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Financiere des Professionnels Fonds d investissement inc. Acquires 9,474 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Promising Biotech Stocks To Follow NowFebruary 17th - MarketBeat
Private Advisor Group LLC Grows Position in Danaher Co. (NYSE:DHR) - MarketBeat
Lateral Flow Immunoassay (LFIA) Based Rapid Test Market Report 2025: Key Trends, Major Players, Opportunities, Strategies, M&As, 2018-2023, 2028F, 2033F - GlobeNewswire Inc.
D.A. Davidson & CO. Purchases 1,541 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Danaher Corp appoints new director, amends incentive plan - Investing.com
Danaher raises dividend to $0.32, up 18.5% from prior - Investing.com
P/E Ratio Insights for Danaher - Benzinga
20,000 Shares in Danaher Co. (NYSE:DHR) Purchased by ICICI Prudential Asset Management Co Ltd - MarketBeat
Jacobson & Schmitt Advisors LLC Boosts Stake in Danaher Co. (NYSE:DHR) - MarketBeat
Private Wealth Partners LLC Increases Holdings in Danaher Co. (NYSE:DHR) - MarketBeat
Bryn Mawr Capital Management LLC Sells 49,603 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Danaher Co. (NYSE:DHR) Shares Sold by Atria Wealth Solutions Inc. - MarketBeat
TigerOak Management L.L.C. Invests $1.25 Million in Danaher Co. (NYSE:DHR) - MarketBeat
Bank Pictet & Cie Europe AG Increases Holdings in Danaher Co. (NYSE:DHR) - MarketBeat
Americana Partners LLC Acquires 23,472 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
New Mexico Educational Retirement Board Has $7.03 Million Position in Danaher Co. (NYSE:DHR) - MarketBeat
Danaher Co. (NYSE:DHR) Shares Sold by Rhumbline Advisers - MarketBeat
Danaher Co. (NYSE:DHR) Stake Decreased by State of New Jersey Common Pension Fund D - MarketBeat
Danaher Co. (NYSE:DHR) Shares Sold by WealthPLAN Partners LLC - MarketBeat
Principal Financial Group Inc. Sells 79,930 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Danaher Co. (NYSE:DHR) Stock Holdings Increased by Schubert & Co - MarketBeat
Autumn Glory Partners LLC Has $303,000 Holdings in Danaher Co. (NYSE:DHR) - MarketBeat
Vontobel Holding Ltd. Raises Stock Position in Danaher Co. (NYSE:DHR) - MarketBeat
Timber Creek Capital Management LLC Sells 1,326 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Danaher Co. (NYSE:DHR) Shares Sold by New York State Common Retirement Fund - MarketBeat
Danaher Co. (NYSE:DHR) Shares Sold by J.P. Marvel Investment Advisors LLC - MarketBeat
Biotech Stocks Worth WatchingFebruary 15th - MarketBeat
Braun Stacey Associates Inc. Sells 1,391 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Truist Financial Corp Has $87.26 Million Stake in Danaher Co. (NYSE:DHR) - MarketBeat
Sanctuary Advisors LLC Has $17.83 Million Stock Holdings in Danaher Co. (NYSE:DHR) - MarketBeat
Figure 8 Investment Strategies LLC Invests $2.10 Million in Danaher Co. (NYSE:DHR) - MarketBeat
New York State Teachers Retirement System Sells 33,045 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Danaher Co. (NYSE:DHR) Shares Bought by Bogart Wealth LLC - MarketBeat
Compagnie Lombard Odier SCmA Has $497,000 Position in Danaher Co. (NYSE:DHR) - MarketBeat
First Merchants Corp Sells 1,303 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Danaher (NYSE:DHR) Sets New 1-Year LowTime to Sell? - MarketBeat
CIBC Asset Management Inc Buys 49,964 Shares of Danaher Co. (NYSE:DHR) - MarketBeat
Danaher Corp Stock (DHR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.98%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):